Novadiscovery Archives | Be Korea-savvy

Home / Posts tagged Novadiscovery

Novadiscovery Announces Nature Communications Paper on Modeling the Disruption to Respiratory Clinical Trials Due to Mitigation Measures Against COVID-19

Lyon, France, 13 April 13 (Korea Bizwire) – Novadiscovery (NOVA), a leading health tech company using in silico clinical trials to predict drug efficacy and optimize clinical trial development, today announces the publication of a novel model of respiratory tract infections (RTI) in Nature Communications to address the uncertainties resulting from non-pharmaceutical interventions (NPIs) against COVID-19 on clinical trials. The paper was [...]

Consortium Including ElsaLys Biotech and Novadiscovery Awarded €3.35 Million by Bpifrance to Advance Inolimomab in Graft-versus-host Disease

Lyon, France, Jan. 19 (Korea Bizwire) – The Silikotac Program consortium, consisting of ElsaLys Biotech, Novadiscovery (“NOVA”) and two expert academic teams from Hôpital St Louis (Paris) and Hôpital Henri Mondor (Paris), has been awarded €3.35 million in non-dilutive funding by Bpifrance to support development of inolimomab in graft-versus-host disease (GvHD), the main complication that [...]

Novadiscovery Announces Key Collaboration with Janssen France to Provide in Silico Based Decision Support for Clinical Development

Lyon, France, Dec. 17 (Korea Bizwire) – Novadiscovery, a leading health tech company offering a best-in-class clinical trial simulation platform, Jinkō®, to predict drug efficacy and optimize clinical trial development, today announces that it has entered into a collaboration with Janssen France to provide in silico based decision support for its clinical development pipeline. Novadiscovery is committed [...]